Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
European Journal of Medicinal Chemistry
|
October 6, 2024
First fragment-based screening identifies new chemotypes inhibiting ERAP1-metalloprotease
Vasileios Fougiaxis, Valentina Barcherini, Milena M Petrovic, et al.
Journal of Biomolecular Screening
|
May 10, 2014
Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737
Anne-Laure Mathieu, Olivier Sperandio, Virginie Pottiez, et al.
European Journal of Medicinal Chemistry
|
July 17, 2023
Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump
Nina Compagne, Juan-Carlos Jiménez-Castellanos, Virginie Meurillon, et al.
British Journal of Pharmacology
|
May 30, 2024
Insulin-degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver
Marine Andres, Nathalie Hennuyer, Khamis Zibar, et al.
Nature Medicine
|
April 21, 2015
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
Caroline Bonner, Julie Kerr-Conte, Valéry Gmyr, et al.
ACS Infectious Diseases
|
February 4, 2020
Fragment-Based Optimized EthR Inhibitors with <i>in Vivo</i> Ethionamide Boosting Activity
Baptiste Villemagne, Arnaud Machelart, Ngoc Chau Tran, et al.
Frontiers in Molecular Neuroscience
|
January 21, 2022
Farnesoid X Receptor Activation in Brain Alters Brown Adipose Tissue Function via the Sympathetic System
Benjamin Deckmyn, Dorothée Domenger, Chloé Blondel, et al.
European Journal of Medicinal Chemistry
|
July 6, 2019
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening
Florence Leroux, Damien Bosc, Terence Beghyn, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 29, 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification
Léo Faïon, Kamel Djaout, Catalin Pintiala, et al.
European Journal of Medicinal Chemistry
|
November 24, 2021
Identification of indole-based activators of insulin degrading enzyme
Nicolas Kraupner, Chau Phi Dinh, Xiaoan Wen, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
European Journal of Medicinal Chemistry
|
October 6, 2024
First fragment-based screening identifies new chemotypes inhibiting ERAP1-metalloprotease
Vasileios Fougiaxis, Valentina Barcherini, Milena M Petrovic, et al.
Journal of Biomolecular Screening
|
May 10, 2014
Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737
Anne-Laure Mathieu, Olivier Sperandio, Virginie Pottiez, et al.
European Journal of Medicinal Chemistry
|
July 17, 2023
Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump
Nina Compagne, Juan-Carlos Jiménez-Castellanos, Virginie Meurillon, et al.
British Journal of Pharmacology
|
May 30, 2024
Insulin-degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver
Marine Andres, Nathalie Hennuyer, Khamis Zibar, et al.
Nature Medicine
|
April 21, 2015
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
Caroline Bonner, Julie Kerr-Conte, Valéry Gmyr, et al.
ACS Infectious Diseases
|
February 4, 2020
Fragment-Based Optimized EthR Inhibitors with <i>in Vivo</i> Ethionamide Boosting Activity
Baptiste Villemagne, Arnaud Machelart, Ngoc Chau Tran, et al.
Frontiers in Molecular Neuroscience
|
January 21, 2022
Farnesoid X Receptor Activation in Brain Alters Brown Adipose Tissue Function via the Sympathetic System
Benjamin Deckmyn, Dorothée Domenger, Chloé Blondel, et al.
European Journal of Medicinal Chemistry
|
July 6, 2019
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening
Florence Leroux, Damien Bosc, Terence Beghyn, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 29, 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification
Léo Faïon, Kamel Djaout, Catalin Pintiala, et al.
European Journal of Medicinal Chemistry
|
November 24, 2021
Identification of indole-based activators of insulin degrading enzyme
Nicolas Kraupner, Chau Phi Dinh, Xiaoan Wen, et al.
Page
of 9